NeuroGeneces, Inc. — SEC Form D Filing
NeuroGeneces, Inc. filed an SEC Form D on May 1, 2026, reporting $425K raised in Health Technology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- May 1, 2026
- Amount reported
- $425K
- Round stage
- Seed
- Industry
- Health Technology
- Website
- https://neurogeneces.com/
What the company does
Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
There is a need for early detection of changes in brain function to enable timely interventions, particularly because slow-wave sleep plays a crucial role in memory consolidation.
Solution
NeuroGeneces offers a sleep headband that captures brain activity and uses AI algorithms to measure neurophysiological biomarkers, potentially enhancing memory consolidation through the synchronization of brain waves with sound.
Why now
There is a growing awareness of brain health and the importance of sleep for cognitive functions, making accessible at-home assessments timely and relevant.
Verdict
Investors opted in because of the urgent need for accessible brain health monitoring, not because of a proven market fit. They were implicitly betting on the convergence of increased consumer health awareness and innovative technology to create a unique solution. However, the limited upside lies in the product’s dependency on consumer adoption amidst the crowded wellness market and the risks associated with unvalidated claims.
Source: SEC EDGAR Form D filing